The Netherlands based Clondalkin Group plans to increase its position in the European pharmaceutical and healthcare sector. The group’s Specialist Packaging Division now has eight PS 9000:2000 certified manufacturing sites across Europe, offering extensive capabilities in cartons, labels, leaflets, literature and inserts/outserts.
The division’s expansion has been supported by a multi-million Euro investment programme over the past two years. It is also ‘actively pursuing acquisitions of packaging companies that occupy strong pharmaceutical and healthcare market positions’, the most recent, in January 2010, being the purchase of Puerto Rican pharmaceutical inserts and labels manufacturer Lehigh Press.
Pharmaceutical and healthcare now account for approximately 25% of the Clondalkin Group’s €800 million total annual sales.
External weblinksConverting Today is not responsible for the content of external internet sites.Clondalkin
